The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of noncancerous tumors on ...

As of Jan. 29, the FDA has approved more than a dozen glucagon-like peptide-1 receptor agonists for diabetes, weight loss, cardiovascular disease and other indications.

The U.S. Food and Drug Administration said on Tuesday it has approved SpringWorks Therapeutics' drug to treat a type of rare ...

The US Food and Drug Administration has approved mirdametinib for the treatment of neurofibromatosis type 1 (NF1) in adults ...

Short chains of amino acids can form drug delivery nanoparticles and boost the properties of potential medicines ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

GLP-1 agonists mimic the natural hormone glucagon-like peptide-1 ... for a full list of side effects. Zepbound is a GLP-1 agonist containing tirzepatide, the same active ingredient found in Mounjaro.

The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine ... We've added you to our mailing list.